找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Continuous Dopaminergic Stimulation in Parkinson’s Disease; Proceedings of the W J. A. Obeso,R. Horowski,C. D. Marsden Conference proceedin

[復(fù)制鏈接]
樓主: VER
31#
發(fā)表于 2025-3-26 22:38:38 | 只看該作者
https://doi.org/10.1007/978-3-322-80731-1infusion together with a small dose of levodopa (plus DDI) are effective treatment for “on-off” fluctuations in Parkinson’s disease, but the frequency of adverse effects limits the number of patients who can be treated successfully with this technique.
32#
發(fā)表于 2025-3-27 03:04:14 | 只看該作者
33#
發(fā)表于 2025-3-27 07:14:10 | 只看該作者
34#
發(fā)表于 2025-3-27 11:00:59 | 只看該作者
Continuous subcutaneous lisuride infusions in Parkinson’s diseaseinfusion together with a small dose of levodopa (plus DDI) are effective treatment for “on-off” fluctuations in Parkinson’s disease, but the frequency of adverse effects limits the number of patients who can be treated successfully with this technique.
35#
發(fā)表于 2025-3-27 14:18:46 | 只看該作者
Pharmacokinetics of lisuride after subcutaneous infusiontion of the infusion, concentrations declined with a half-life of 1.4 ± 0.4 hour. The total clearance of lisuride was 20 ± 6 ml/min/kg. Due to the low interpatient variability of plasma levels, a good control of clinical effects is to be expected.
36#
發(fā)表于 2025-3-27 18:32:34 | 只看該作者
Lisuride infusion pump in Parkinson’s disease. A report of two casesough a net increase in the number of hours spent “on”. Dyskinesias remained unmodified. Limiting psychiatric side effects were observed in one of the patients..Practical and technical aspects of the management of this therapeutic method are discussed.
37#
發(fā)表于 2025-3-28 00:15:38 | 只看該作者
Pathogenetic studies of motor fluctuations in Parkinson’s diseasete advanced Parkinson’s disease. Since levodopa clearance from the general circulation was found to be similar in patients with wearing-off or on-off phenomena and those with a stable response to levodopa, peripheral pharmacokinetic factors are unlikely to be involved. Efficacy half-time for levodop
38#
發(fā)表于 2025-3-28 05:37:09 | 只看該作者
The case for and concerns about continuous dopamine stimulation in Parkinson’s diseaseluctations in response (“on-off”). This should be manageable with innovative delivery systems for the drugs. However further studies are required to determine if continuous dopaminergic stimulation will be complicated by increased levels of drug metabolites or down regulation of dopaminergic neurotr
39#
發(fā)表于 2025-3-28 07:24:51 | 只看該作者
40#
發(fā)表于 2025-3-28 12:56:34 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-26 10:37
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
盐津县| 扬中市| 赤水市| 都昌县| 亳州市| 娱乐| 邢台市| 北安市| 吴堡县| 高要市| 蒙阴县| 万山特区| 遂平县| 大理市| 准格尔旗| 满城县| 新密市| 平远县| 普安县| 商洛市| 井陉县| 邓州市| 中山市| 江达县| 云梦县| 新巴尔虎左旗| 柞水县| 阆中市| 洛南县| 贵州省| 金平| 隆尧县| 怀宁县| 禹州市| 东海县| 九江市| 宜城市| 桦川县| 南康市| 忻州市| 玉田县|